Clinical data | |
---|---|
Other names | Fenprin, Fenpyramine, Miospasm |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H20N2 |
Molar mass | 288.394 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Milverine (Fenprin, Fenpyramine, Miospasm) is a spasmolytic (antispasmodic) agent that was developed in the latter half of the 20th century.
The therapeutic use of fenpyramin as a platelet-antiaggregating and antithrombotic as well as vasodilating and antianginous medicine was also identified.
Milverine is a bifunctional molecule; one half of the molecule contains 3,3-Diphenylpropylamine and the other half of the molecule contains fampridine.
Synthesis
The chemical synthesis of milverine was identified.
Conjugate soft addition of benzene to cinnamic acid (1) gives 3,3-diphenylpropionic acid (2). Halogenation with thionyl chloride gives 3,3-diphenylpropionyl chloride (3). Schotten-Baumann reaction with 4-aminopyridine (Fampridine) (4) gives 3,3-diphenyl-N-(4-pyridyl)propionamide (5). The last step involves reduction of the amide bond giving milverine (6), respectively.
References
- Carpenedo F, Santi-soncin E. . Minerva Med. 1970;61(43):2417-24. PMID 5425728.
- Baldi, F. et al, Curr. Ther. Res., 1984,36, 267 (pharmacol)
- Fossati A, Sosio A, Pellegrini R, Frigo GM, D'Angelo L, Lecchini S, Marcoli M, Caravaggi M, Crema A. Milverine: in vitro and in vivo activity on the animal and human colon. Farmaco Prat. 1986 Sep;41(9):279-89. PMID 3770157.
- Rinaldo Pellegrini, Gaetano Clavenna, Piero Bellani, EP0143082 (1985 to RBS PHARMA (ROGER BELLON SCHOUM) S.p.A.).
- Paolo Masi, Angela Monopoli, Adone Carlo Saravalle, Cesare Zio, DE3002909 (1980 to Italiana Schoum Spa).
Urologicals, including antispasmodics (G04B) | |
---|---|
Acidifiers | |
Urinary antispasmodics (primarily antimuscarinics) | |
Other urologicals |
|
Irritable bowel syndrome (IBS) | |
---|---|
Management | |
Related topics |